Epidemiological, phenotypic and genotypic features of the <i>A. baumannii</i> studied.

<p>PFGE, pulsed-field gel electrophoresis; MLST, Multilocus sequence typing; ST, sequence type;</p><p>IMP, imipenem; MEM, meropenem.</p>a<p>Number of strains belonging to a single ST.</p>b<p>These PFGE types were each observed in two distinct centres.</p><p>Epidemiological, phenotypic and genotypic features of the <i>A. baumannii</i> studied.</p

Geographical distribution of <i>A. baumannii</i> producing acquired oxacillinase enzymes.

<p>Carbapenem-hydrolyzing OXA-23, OXA-58 and OXA-24 are indicated by stars, circles and triangles, respectively.</p

Genetic diversity of carbapenem-non susceptible <i>A. baumannii</i> from France.

<p>Each circle represents a sequence type (ST), which number is given besides the circle. The size of circles is related to the number of isolates. Grey zones between circles represent clonal complexes. The relative positioning of clonal complexes and singletons STs is not necessarily related to their genetic proximity. A: Coloured sectors inside circles denote the proportion of isolates with each enzyme or combination thereof, as indicated in the key. B: Coloured sectors inside circles denote the proportion of isolates from each healthcare centre (arbitrary colours, with no correspondence with those in Fig. 2A).</p

Seasonal vaccine uptake among ILI cases included in the seasonal vaccine effectiveness analysis.

<p>Seasonal vaccine uptake among ILI cases included in the seasonal vaccine effectiveness analysis.</p

Field effectiveness of pandemic vaccines, by case definition, age group and study period.

<p>Field effectiveness of pandemic vaccines, by case definition, age group and study period.</p

Pandemic vaccine uptake among laboratory-confirmed cases included in the pandemic vaccine effectiveness analysis.

<p>Pandemic vaccine uptake among laboratory-confirmed cases included in the pandemic vaccine effectiveness analysis.</p

Seasonal vaccine uptake among laboratory-confirmed cases included in the seasonal vaccine effectiveness analysis.

<p>Seasonal vaccine uptake among laboratory-confirmed cases included in the seasonal vaccine effectiveness analysis.</p

Field effectiveness of seasonal vaccines, by case definition, age group and study period.

<p>Field effectiveness of seasonal vaccines, by case definition, age group and study period.</p

Weekly ILI incidence rates during the 2009–2010 pandemic in France (including Corsica, excluding overseas territories).

<p>Black curve: national ILI incidence rate and 95% confidence interval. Red curve: national ILI incidence rate in the 0 to 4 year-old age group; Blue: in the 5 to 14 year-old age group; Green: in the 15 to 64 year-old age group; Violet: in the ≥65 year-old age group.</p

Pandemic vaccine uptake among ILI cases included in the pandemic vaccine effectiveness analysis.

<p>Pandemic vaccine uptake among ILI cases included in the pandemic vaccine effectiveness analysis.</p